Loss of stearoyl-CoA desaturase 1 rescues cardiac function in obese leptin-deficient mice.

Pawel Dobrzyn, Agnieszka Dobrzyn, Makoto Miyazaki, James M Ntambi
Author Information
  1. Pawel Dobrzyn: Laboratory of Cell Signaling and Metabolic Disorders, Nencki Institute of Experimental Biology, Warsaw, Poland. adobrzyn@nencki.gov.pl

Abstract

The heart of leptin-deficient ob/ob mice is characterized by pathologic left ventricular hypertrophy along with elevated triglyceride (TG) content, increased stearoyl-CoA desaturase (SCD) activity, and increased myocyte apoptosis. In the present study, using an ob/ob;SCD1(-/-) mouse model, we tested the hypothesis that lack of SCD1 could improve steatosis and left ventricle (LV) function in leptin deficiency. We show that disruption of the SCD1 gene improves cardiac function in ob/ob mice by correcting systolic and diastolic dysfunction without affecting levels of plasma TG and FFA. The improvement is associated with reduced expression of genes involved in FA transport and lipid synthesis in the heart, as well as reduction in cardiac FFA, diacylglycerol, TG, and ceramide levels. The rate of FA beta-oxidation is also significantly lower in the heart of ob/ob;SCD1(-/-) mice compared with ob/ob controls. Moreover, SCD1 deficiency reduces cardiac apoptosis in ob/ob mice due to increased expression of antiapoptotic factor Bcl-2 and inhibition of inducible nitric oxide synthase and caspase-3 activities. Reduction in myocardial lipid accumulation and inhibition of apoptosis appear to be one of the main mechanisms responsible for improved LV function in ob/ob mice caused by SCD1 deficiency.

References

  1. Science. 2002 Jul 12;297(5579):240-3 [PMID: 12114623]
  2. J Biol Chem. 2003 Sep 5;278(36):33904-11 [PMID: 12815040]
  3. Endocrinology. 2003 Aug;144(8):3483-90 [PMID: 12865329]
  4. Am J Cardiovasc Drugs. 2004;4(4):201-9 [PMID: 15285695]
  5. Biochim Biophys Acta. 2002 May 21;1587(1):75-82 [PMID: 12009427]
  6. Proc Natl Acad Sci U S A. 2000 Feb 15;97(4):1784-9 [PMID: 10677535]
  7. Arch Biochem Biophys. 2007 Jun 15;462(2):171-5 [PMID: 17467652]
  8. J Card Fail. 2000 Sep;6(3):243-9 [PMID: 10997751]
  9. Cardiovasc Res. 2006 Feb 1;69(2):440-9 [PMID: 16337160]
  10. J Biol Chem. 2001 Oct 19;276(42):39455-61 [PMID: 11500518]
  11. Circ Res. 2002 Mar 22;90(5):594-601 [PMID: 11909824]
  12. Oncogene. 2000 Jul 20;19(31):3508-20 [PMID: 10918609]
  13. J Biol Chem. 2002 Jun 21;277(25):22847-52 [PMID: 11929874]
  14. Circulation. 2003 Aug 12;108(6):754-9 [PMID: 12885755]
  15. Am J Physiol Endocrinol Metab. 2008 Feb;294(2):E357-64 [PMID: 18042664]
  16. J Lipid Res. 2008 Oct;49(10):2101-12 [PMID: 18515784]
  17. Cell Cycle. 2008 Mar 1;7(5):560-5 [PMID: 18239469]
  18. Can J Biochem Physiol. 1959 Aug;37(8):911-7 [PMID: 13671378]
  19. Biochim Biophys Acta. 1986 Feb 28;875(3):510-5 [PMID: 3947656]
  20. Proc Natl Acad Sci U S A. 2002 Aug 20;99(17):11482-6 [PMID: 12177411]
  21. Eur J Biochem. 1994 Aug 1;223(3):751-8 [PMID: 7914488]
  22. Circ Res. 2006 Jan 6;98(1):119-24 [PMID: 16339484]
  23. Biochim Biophys Acta. 2003 Jun 10;1632(1-3):16-30 [PMID: 12782147]
  24. Endocrinology. 2003 Dec;144(12):5159-65 [PMID: 12960011]
  25. Methods Enzymol. 2000;311:3-9 [PMID: 10563304]
  26. Circ Res. 2007 Oct 12;101(8):759-67 [PMID: 17932333]
  27. Exp Cell Res. 2007 Feb 15;313(4):816-23 [PMID: 17239851]
  28. Proc Natl Acad Sci U S A. 1999 Mar 2;96(5):2327-32 [PMID: 10051641]
  29. Biochem Biophys Res Commun. 2009 Mar 20;380(4):818-22 [PMID: 19338759]
  30. J Clin Invest. 2006 Mar;116(3):581-9 [PMID: 16511590]
  31. Proc Natl Acad Sci U S A. 2004 Apr 27;101(17):6409-14 [PMID: 15096593]
  32. Proc Natl Acad Sci U S A. 2003 Sep 16;100(19):11110-5 [PMID: 12960377]
  33. J Biol Chem. 1998 Dec 4;273(49):32487-90 [PMID: 9829981]
  34. Proc Natl Acad Sci U S A. 2004 Sep 14;101(37):13624-9 [PMID: 15347805]
  35. Am J Pathol. 1997 Nov;151(5):1257-63 [PMID: 9358751]
  36. Am J Physiol Endocrinol Metab. 2005 Mar;288(3):E599-607 [PMID: 15562249]
  37. Am J Physiol Lung Cell Mol Physiol. 2003 Jun;284(6):L1082-92 [PMID: 12576296]

Grants

  1. R01162388/PHS HHS

MeSH Term

Adipose Tissue
Adiposity
Animals
Apoptosis
Blood Pressure
Body Weight
Caspase 3
Ceramides
Epididymis
Fatty Acids
Female
Gene Knockdown Techniques
Gene Knockout Techniques
Heart
Leptin
Male
Mice
Myocardium
Nitric Oxide Synthase Type II
Obesity
Oxidation-Reduction
Stearoyl-CoA Desaturase
Ventricular Function, Left

Chemicals

Ceramides
Fatty Acids
Leptin
Nitric Oxide Synthase Type II
Scd1 protein, mouse
Stearoyl-CoA Desaturase
Caspase 3

Word Cloud

Created with Highcharts 10.0.0ob/obmiceSCD1functioncardiacheartTGincreasedapoptosisdeficiencyleptin-deficientleftstearoyl-CoAdesaturase-/-LVlevelsFFAexpressionFAlipidinhibitioncharacterizedpathologicventricularhypertrophyalongelevatedtriglyceridecontentSCDactivitymyocytepresentstudyusingmousemodeltestedhypothesislackimprovesteatosisventricleleptinshowdisruptiongeneimprovescorrectingsystolicdiastolicdysfunctionwithoutaffectingplasmaimprovementassociatedreducedgenesinvolvedtransportsynthesiswellreductiondiacylglycerolceramideratebeta-oxidationalsosignificantlylowercomparedcontrolsMoreoverreducesdueantiapoptoticfactorBcl-2induciblenitricoxidesynthasecaspase-3activitiesReductionmyocardialaccumulationappearonemainmechanismsresponsibleimprovedcausedLoss1rescuesobese

Similar Articles

Cited By